Johnson TR - Search Results

1

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.

Kines RC, Zarnitsyn V, Johnson TR, Pang YY, Corbett KS, Nicewonger JD, Gangopadhyay A, Chen M, Liu J, Prausnitz MR, Schiller JT, Graham BS. Kines RC, et al. Among authors: johnson tr. PLoS One. 2015 Mar 18;10(3):e0120797. doi: 10.1371/journal.pone.0120797. eCollection 2015. PLoS One. 2015. PMID: 25785935 Free PMC article.

2

Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Johnson TR, Johnson CN, Corbett KS, Edwards GC, Graham BS. Johnson TR, et al. Among authors: johnson cn. PLoS One. 2011 Jan 28;6(1):e16458. doi: 10.1371/journal.pone.0016458. PLoS One. 2011. PMID: 21297989 Free PMC article.

3

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB. Graham BS, et al. Among authors: johnson tr. Mucosal Immunol. 2010 Sep;3(5):475-86. doi: 10.1038/mi.2010.31. Epub 2010 Jun 16. Mucosal Immunol. 2010. PMID: 20555315 Free PMC article.

4

Respiratory syncytial virus immunobiology and pathogenesis.

Graham BS, Rutigliano JA, Johnson TR. Graham BS, et al. Among authors: johnson tr. Virology. 2002 May 25;297(1):1-7. doi: 10.1006/viro.2002.1431. Virology. 2002. PMID: 12083830 Free article. Review. No abstract available.

5

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Johnson TR, Parker RA, Johnson JE, Graham BS. Johnson TR, et al. Among authors: johnson je. J Immunol. 2003 Feb 15;170(4):2037-45. doi: 10.4049/jimmunol.170.4.2037. J Immunol. 2003. PMID: 12574374

6

Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.

Johnson TR, Graham BS. Johnson TR, et al. Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.

7

Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Johnson TR, Rothenberg ME, Graham BS. Johnson TR, et al. J Leukoc Biol. 2008 Sep;84(3):748-59. doi: 10.1189/jlb.0907621. Epub 2008 Jun 2. J Leukoc Biol. 2008. PMID: 18519743 Free PMC article.

8

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS. Liu J, et al. Among authors: johnson tr. J Virol. 2009 May;83(10):4934-41. doi: 10.1128/JVI.02140-08. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264776 Free PMC article.

9

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.

Johnson TR, Rao S, Seder RA, Chen M, Graham BS. Johnson TR, et al. Vaccine. 2009 May 18;27(23):3045-52. doi: 10.1016/j.vaccine.2009.03.026. Epub 2009 Apr 3. Vaccine. 2009. PMID: 19428918 Free PMC article.

10

Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS. Liu J, et al. Among authors: johnson tr. J Virol. 2010 Oct;84(20):10501-9. doi: 10.1128/JVI.00963-10. Epub 2010 Aug 4. J Virol. 2010. PMID: 20686045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters